Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

The Oil Crisis Saudi Arabia Can't Solve

Saudi Arabia's CEO Amin Nasr's message to the press that oil flows to the market are guaranteed, should be taken with a pinch of salt. Looking at the current volatility in the Persian/Arabian Gulf and the possibility of a temporary closure of the Strait of Hormuz, the Ar...

The Oil Crisis Saudi Arabia Can't Solve

Saudi Arabia's CEO Amin Nasr's message to the press that oil flows to the market are guaranteed, should be taken with a pinch of salt. Looking at the current volatility in the Persian/Arabian Gulf and the possibility of a temporary closure of the Strait of Hormuz, the Ar...

Surprise decision in the UK to thwart a No-Deal Brexit changed the dynamics of the markets

Our August 19 th prediction of a market breakdown, as well as our continued research suggesting a breakdown in price was the most likely outcome, is a combination of technical analysis, predictive modeling and our understanding of the market dynamics at play throughout the wo...

FDA Accepts NDA for Global Blood Therapeutics' Sickle Cell Drug; Shares Up 14%

Shares of Global Blood Therapeutics are trading more than 14% higher after the FDA accepted its New Drug Application filing for Voxelotor, a drug used in the treatment of sickle cell disease. Earlier today clinical-stage biopharmaceutical firm Global Blood Therapeuti...

The Pressures in the Oil Market Are Building

Crude oil bulls don’t seem to be making much progress these days. The situation is tense, and black gold keeps hovering ever so close to its recent lows. Can the bulls get their act together and avert the fall of a cliff ahead? Looking at daily chart, w...

The Debt Time Bomb: Amend, Extend and Pretend

“Hey Marin, we don’t invest in gold companies for yield. We invest in gold stocks as a hedge to the overall markets. And for leverage on the price of gold.” What a bunch of nonsense . Have you ever heard the phrase, “What a gold...

Australia May Be the Saving Grace for the Rare Earth Metals Market

When Colorado-based Molycorp Inc. filed for bankruptcy in 2015, the U.S. lost its sole remaining miner and producer of rare earth elements (REEs)—those inconspicuous metals with unpronounceable names like praseodymium, yttrium and gadolinium. The company&CloseCurlyQuo...

Biotech Identifies Antibody with 100% SARS-CoV-2 Inhibition

The goal of Sorrento Therapeutics to develop a Covid-19 antibody cocktail, including its progress, next steps and market opportunity, is reviewed in a Dawson James report. In a May 26 research note, Dawson James analyst Jason Kolbert reported that Sorrento Therape...

Masochism and the Average Gold Investor

Masochism and the Average Gold Investor Source: Michael J. Ballanger for Streetwise Reports 04/22/2019 Sector expert Michael Ballanger discusses generational attitudes toward investing and how they are affecting the precious metals markets. Masochism: "...

Three safe-haven reasons to own gold

“It’s the tail that wags the dog” is defined by Urban Dictionary as a way of persuading a large group of people. The phrase is usually employed in a situation wherein a cause that expects to elicit a certain effect, is in fact reversed. ...
1 2